Skip to main content
Article
Epigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor–Resistant Cutaneous Melanomas
Journal of Investigative Dermatology (2015)
  • Jinhua Wang, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
  • Sharon K. Huang, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
  • Diego M. Marzese, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
  • Sandy C. Hsu, Sequencing Center, John Wayne Cancer Institute, Santa Monica, California, USA
  • Neal P. Kawas, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
  • Kelly K. Chong, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California, USA
  • Georgina V. Long, University of Sydney
  • Alexander M. Menzies, University of Sydney
  • Richard A. Scolyer, University of Sydney
  • Richard A. Scolyer, Royal Prince Alfred Hospital
  • Sivan Izraely, Tel Aviv University
  • Orit Sagi-Assif, Tel Aviv University
  • Isaac P. Witz, Tel Aviv University
  • Dave S.B. Hoon
Disciplines
Publication Date
February 1, 2015
DOI
10.1038/jid.2014.418
Citation Information
Jinhua Wang, Sharon K. Huang, Diego M. Marzese, Sandy C. Hsu, et al.. "Epigenetic Changes of EGFR Have an Important Role in BRAF Inhibitor–Resistant Cutaneous Melanomas" Journal of Investigative Dermatology Vol. 135 Iss. 2 (2015) p. 532 - 541
Available at: http://works.bepress.com/dave-hoon/83/